Background: The aim of the present study was to develop a simple nomogram that can be u
dation.
<A>Introduction Diabetes mellitus (DM) is highly prevalent and has become one of the major disease burdens worldwide. 1 In particular, undiagnosed DM is associated with a higher risk of diabetes-related complications 2 and mortality 3 compared with normal glucose tolerance because of the lack of awareness of high blood glucose levels and delayed disease management. Early detection of DM through periodic screening has been recommended 4 for high-risk individuals using 75-g o ral glucose tolerance tests (OGTT), fasting plasma glucose (FPG) tests or HbA1c levels. In a r ecent cost-effectiveness analysis, screening for DM and prediabetes was found to be cost-savi ng among patients at risk compared with no screening. 5 Nevertheless, a targeted screening app roach based on risk assessment and stratification of high-risk subjects should be undertaken to optimize resource allocation and utilization. 6 In order to stratify high-risk subjects for DM screening, risk algorithms for the detection of undiagnosed DM have been developed and validated in different populations and healthcar e settings. [6] [7] [8] [9] However, these risk score algorithms are population specific; the combination of risk factors in each algorithm varies across countries, ethnicities, and levels of income based o n the population in which these algorithms were developed. For the Chinese population, [10] [11] [12] [13] most of the risk algorithms [11] [12] [13] were derived from results of laboratory tests, in addition to so ciodemographic and anthropometric data. Interestingly, the majority of these Chinese DM risk algorithms were developed and validated in low income settings. [10] [11] [12] Little is known about th eir performance, calibration, and discrimination in the detection of undiagnosed DM among C hinese populations in non-low income settings. Furthermore, no nomograms for the identificat ion of undiagnosed DM have been developed, which would be an ideal, simple-to-use graphic al tool to facilitate DM risk assessment and stratification in clinical practice and the communit y setting.
The aims of this study were to present and validate a non-laboratory-and laboratory-bas ed risk assessment algorithm for detecting undiagnosed DM among the Chinese population in a non-low income setting. In addition, a simple and user-friendly nomogram was constructed t o enable clinicians to estimate individual DM risk based on non-laboratory and laboratory risk assessment algorithms. Both tools could inform clinical decision making and enable identific ation of individuals at high risk for DM to undergo further screening tests, thus promoting the early detection of DM in the clinical and community settings. In addition, the study provides i nformation on modifiable risk factors to be targeted by health intervention programs for the re duction of individual DM risk.
<A>Methods <B>Subjects for the development of risk assessment algorithms
This study was part of a Hong Kong professional driver community project to promote health awareness and literacy regarding DM. Details regarding subject recruitment, eligibility criteri a, and interviews have been reported previously. [14] [15] [16] Subjects were excluded if they self-reported to have clinician-diagnosed DM. For each e ligible subject, we retrieved DM risk factor data, including sociodemographic characteristics, lifestyle, past medical history and family history, which were surveyed through structured inte rview questionnaires. Sociodemographic data included the age, gender, and marital status of t he subjects. For lifestyle factors, we considered self-reported drinking status, smoking status, and exercise frequency. For past medical history, gestational DM was defined by self-reported high blood glucose levels during pregnancy in women without a known diagnosis of DM. A s elf-reported history of hypertension was recorded. A positive family history of DM was define d as either first-degree (parents or siblings) or second-degree (grandparents) relatives having DM.
In addition, anthropometric and laboratory assessments were performed on each subject at baseline. For anthropometric assessment, we measured body mass index (BMI), systolic bl ood pressure (SBP), diastolic blood pressure (DBP), and waist circumference. Blood samples were taken for the measurement of FPG and 2-h post-load plasma glucose in the 75-g OGTT t o determine glycemic status, as well as to determine the full lipid profile, including triglycerid es (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-densit y lipoprotein cholesterol (LDL-C), to assess DM risk. Plasma glucose, TG, TC, and HDL-C w ere measured using the Abbott Architect c16000 chemistry analyzer, whereas LDL-C was deri ved from the Friedewald formula.
Undiagnosed DM was defined as subjects with FPG ≥7.0 mmol/L or 2-h post-load plas ma glucose ≥11.1 mmol/L in the 75-g OGTT.
<B>Development and validation of risk assessment algorithms
In all, 3357 subjects completed the questionnaire survey and underwent anthropometric and la boratory assessment during the study period. Simple random sampling was performed to selec t 2518 subjects from the total number of subjects (75% of the total sample) as the developmen t sample. The remaining 25% formed the validation sample.
Data from the development sample (n = 2518) on the following DM risk factors were us Based on undiagnosed DM as the outcome, significant risk factors with P < 0.05 in a ste pwise binary logistic regression model were retained in the final risk assessment model. Each risk factor was assigned a weighting in the risk score using respective β-coefficients multipli ed by 10 and rounded to the nearest integer. The risk score for each subject would be the sum of risk score contributed by each risk factor identified by the final risk assessment model.
Non-laboratory-and laboratory-based risk assessment algorithms were validated externa lly using data for the remaining 839 subjects in the validation sample; these subjects had not b een used for algorithm development. The accuracy, calibration, and discrimination of the risk algorithms to detect undiagnosed DM were compared against six previously published DM ris k assessment algorithms, 10, 12, 13, [17] [18] [19] of which three were developed in Chinese populations (N ew Chinese Diabetes Risk Score, 10 Qingdao Diabetes Risk Score, 12 and Southern Chinese Ris 
<A>Results
Descriptive characteristics of the 3357 study subjects overall and by analysis samples are pres ented in Table 1 . Of 3357 subjects without a prior history of DM, 271 (8.1%) had undiagnose d DM. The prevalence of undiagnosed DM between the development and validation samples did not differ significantly (8.3% vs 7.3%; P = 0.325). The mean (± SD) age of subjects was 5 0.9 ± 7.6 years. Most subjects were male (92.7%) and non-smokers (80.5%). In terms of non-l aboratory-based clinical characteristics, 31.4% of subjects had a family history of DM, 51.2%
had general obesity, 48.1% had central obesity, and 32.2% had uncontrolled blood pressure w ith either SBP >140 mmHg or DBP >90 mmHg; 12.8% of subjects had history of hypertensio n and the subjects in the validation sample were more likely to have hypertension than those i n the development sample. There were no significant differences in laboratory-based clinical c haracteristics between the development and validation samples. antly associated with undiagnosed DM in the regression analysis for the laboratory-based risk assessment algorithm. Significant risk factors were used to assign weighted scores, and the tot al risk score for each subject was the sum of all risk scores allocated to each individual risk fa ctor. The scores for non-laboratory-and laboratory-based risk assessment algorithms ranged fr om 0 to 33 and from 0 to 37, respectively. Youden's index suggesting the optimal cut-off valu e for undiagnosed DM was 18 for both risk assessment algorithms. At the optimal cut-off valu e ≥18, the sensitivity and specificity were 57.9% and 68.9%, respectively, for the non-laborato ry-based algorithm and 66.2% and 60.2%, respectively, for the laboratory-based algorithm.
For the external validation of models, the AUC for the non-laboratory-and laboratory-b ased algorithms was 0.709 and 0.711, respectively, supporting model discrimination. The Hos mer-Lemeshow test with P > 0.05 (0.229 and 0.483, respectively) indicated adequate calibrati on of the non-laboratory-and laboratory-based algorithms. Using the validation sample, the se nsitivity and specificity at the optimal cut-off value ≥18 for the non-laboratory-based risk algo rithm were 63.9% and 67.7%, respectively, whereas those of the laboratory-based risk algorith m were 72.1% and 57.8%, respectively.
Compared with existing risk algorithms, the risk algorithms developed in the present stu dy exhibited adequate accuracy, discrimination, and calibration. Figure 1 shows the nomogra m that graphically calculated the non-laboratory-and laboratory-based risk scores. The lower part of the nomogram shows the predicted probability of the individual having undiagnosed D M in both routine clinical practice and the community setting. From the nomogram, the predic ted prevalence of undiagnosed DM increases gradually from 1% at a total risk score of 0 to 34 % at a total risk score of 33.
<A>Discussion
The present study developed and validated simple non-laboratory-and laboratory-based risk a ssessment algorithms for predicting undiagnosed DM in the general Chinese population. Base d on the risk assessment algorithms, we developed a simple-to-use nomogram ( Fig. 1) for pri mary care clinicians to facilitate risk sharing in such a way that high-risk subjects are identifie d to promote the uptake of DM screening. In addition to risk information sharing, this risk ass essment facilitates the health service provider prioritizing DM prevention strategies and launc hing DM screening in the primary care setting when resources for glycemic testing are limited.
Moreover, risk stratification identified high-risk subjects, who were then encouraged to under go DM screening using the most appropriate screening test. Screened subjects were empower ed to increase their awareness of DM and to make lifestyle modifications.
Risk scores with cut-off values ≥18 had the best combination of sensitivity and specifici ty for detecting undiagnosed DM. Therefore, subjects with risk scores ≥18 were considered to be high-risk subjects recommended to undergo DM screening. Visualization of the nomogra m has important implications for clinicians and subjects. For example, the predicted probabilit y of undiagnosed DM is approximately 15% if subjects score 23 on the non-laboratory-based risk assessment algorithm.
The National Prevalence Health Survey of 46 239 adults in 14 provinces in China found that the prevalence of undiagnosed DM was 6.3%, 21 and a survey conducted in a nationally re presentative sample of 98 658 Chinese adults reported a prevalence of 8.1% in 2010. 22 The pr evalence of undiagnosed DM found in the development (8.3%) and validation (7.3%) samples in the present study is comparable to that in the Chinese population. Thus, the prevalence of u ndiagnosed DM in the present study was comparable to the Hong Kong prevalence of 9.51%, as estimated by the International Diabetes Federation.
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The non-laboratory-based risk assessment algorithm was constructed on the basis of fiv e widely recognized risk factors: age, BMI, family history of DM, exercise frequency, and blo od pressure. This is in line with recent systematic reviews 7, 8 of newly developed risk assessme nt algorithms reporting that the frequently included risk factors are age and BMI, representing measures of body mass. Age group was a main contributor to the risk score for the detection of undiagnosed DM, because we observed a trend for increasing risk score with increasing ag e. Interestingly, there were two modifiable risk factors recognized in our algorithms: BMI and exercise frequency. This implies that health intervention programs, such as body weight moni toring and control and lifestyle interventions, are useful in reducing DM risk in asymptomatic subjects in the Chinese population.
Although the risk factors identified in our algorithms are mostly found in existing algori thms summarized by systematic reviews, 7, 8 there are no existing risk algorithms using the sam e pool of risk factors. Risk factors may be presented in other forms and using alternative defin itions. It should be highlighted that there is no universal consensus regarding the combination of risk factors to be used for the detection of undiagnosed diabetes. Notably, the risk algorith ms developed in one country may not be transferable to other counties, reflected by the poor a bility to calibrate and discriminate the external dataset. For example, two risk algorithms 12,13 d eveloped using the Chinese population did not have satisfactory performance, with an AUC of ≥0.7 in our dataset upon external validation; this could be due, in part, to differences in inco me levels. However, recent studies 24, 25 have not found any clear indication that the addition of ethnicity improves the performance of risk algorithms for predicting diabetes. Therefore, furt her research is required to improve the performance through the additional effects of alternati ve key information, such as spousal history of diabetes.
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A high degree of model discrimination does not necessarily imply identification of true positive diabetes cases. Upon external validation of existing algorithms developed using Cauc asian populations, the AUC of the algorithm of Bang et al. was <0.7. 17 Even though the discri mination of another two algorithms 18, 19 was greater than that of our algorithms, those algorith ms did not achieve a good trade-off between sensitivity and specificity at predefined optimal c ut-off values. For both algorithms, 18, 19 the specificities were unacceptably low although the se nsitivities were at least 90%. Hence, a high degree of discrimination does not necessarily lead to reasonable performance at recommended cut-off values. In such cases, when an algorithm h as a high degree of discrimination upon external validation, new recommended cut-off values may help balance sensitivity and specificity.
The laboratory-based risk assessment algorithm increased the number of risk factors by including factors such as TG; however, this algorithm may not be able to stratify risks of asy mptomatic subjects without prior laboratory testing. Nevertheless, such an algorithm is likely to be used when identifying high-risk subjects in the routine clinical setting, where blood sam ples are routinely collected for lipid profile assessment.
<B>Limitations
Several limitations of present study should be noted. First, our risk algorithms were developed and validated using Chinese data, so they may not be generalizable to non-Chinese populatio ns. However, only two previous studies 27,28 included ethnicity in their algorithms, indicating t hat ethnicity is not a common predictive factor for the prediction of diabetes. Second, there w as a high proportion (92.7%) of male professional drivers in our development and validation s amples. 
Figure 1
Nomogram to predict the probability of undiagnosed diabetes based on non-labora tory-and laboratory-based risk algorithms. The patient's score for each parameter is plotted o n the appropriate scale and vertical lines are drawn to the line of points to obtain the correspo nding scores. All scores are summed to obtain a total points score. The total points score is plo tted on the total points line and a vertical line is drawn down to the bottom line. The correspon ding value shows the predicted probability of undiagnosed diabetes. BMI, body mass index; BP, blood pressure; SBP, systolic BP; DBP, diastolic BP; TC, total ch olesterol; TG, triglycerides; FPG, fasting plasma glucose; WC, waist circumference. 
